HYPERION DEFI, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
HYPERION DEFI, INC. (HYPD) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $151.18 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2025-08-13
- HYPERION DEFI, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-06-30 was $75.59K, a 41.77% decline year-over-year.
- HYPERION DEFI, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-03-31 was $75.59K, a 40.90% decline year-over-year.
- HYPERION DEFI, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2024-06-30 was $129.81K.
- HYPERION DEFI, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2024-03-31 was $127.90K, a 4.48% decline year-over-year.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month |
|---|---|---|
| 2025-06-30 | $75.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $151.18K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $75.59K 10-Q · filed 2025-05-19 | |
| 2024-06-30 | $129.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $257.72K 10-Q · filed 2025-08-13 |
| 2024-03-31 | $127.90K 10-Q · filed 2025-05-19 | |
| 2023-03-31 | $133.91K 10-Q · filed 2023-05-12 | |
| 2022-03-31 | $89.72K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |